Chubb, Toast And A Health Care Stock On CNBC’s ‘Final Trades’

Toast
Amgen Inc.
Chubb Limited

Toast

TOST

0.00

Amgen Inc.

AMGN

0.00

Chubb Limited

CB

0.00

On CNBC’s “Halftime Report Final Trades,” Malcolm Ethridge, managing partner at Capital Area Planning Group, recommended Chubb Limited (NYSE:CB) as his final trade.

On the earnings front, Chubb, on July 21, reported second-quarter earnings of $7.26 per share, which beat the analyst consensus estimate of $6.75 per share. The company reported quarterly sales of $12.768 billion, which missed the analyst consensus estimate of $12.987 billion.

Don’t forget to check out our premarket coverage here

Bill Baruch, founder and CIO of Blue Line Capital, an investment advisor, named Amgen Inc. (NASDAQ:AMGN).

Lending support to his choice, Amgen, on Tuesday, reported better-than-expected second-quarter financial results. raised its FY26 adjusted EPS guidance with its midpoint above estimates and raised its FY26 sales guidance above estimates.

Amgen reported quarterly earnings of $6.29 per share. It beat the analyst consensus estimate of $5.62 per share. The biopharmaceutical company reported quarterly sales of $10.054 billion, which beat the analyst consensus estimate of $9.421 billion.

Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, picked Toast, Inc. (NYSE:TOST).

On Tuesday, Toast posted second quarter earnings of 26 cents per share, which beat the analyst consensus estimate of 20 cents per share. The company’s quarterly sales reached $1.908 billion, beating the analyst consensus estimate of $1.871 billion.

Price Action

  • Amgen shares fell 0.7% to close at $404.85 on Thursday.
  • Chubb shares gained 0.4% to close at $354.03 during the session.
  • Toast shares declined 0.2% to close at $34.72 on Thursday.

Photo via Shutterstock